Sanjay Chanda - Insider Trading & Ownership

Entity
Individual
Location
C/O Anacor Pharmaceuticals, Inc., 1020 East Meadow Circle, Palo Alto, CA
Summary
The estimated net worth of Sanjay Chanda is at least $540K dollars as of March 29, 2024. Sanjay Chanda is the Chief Development Officer of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $540K.
All Insider Reports
All Insider Reports

Ownership of Sanjay Chanda

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ANTX AN2 Therapeutics, Inc. Chief Development Officer $540K Mar 15, 2024

Insider Transactions Reported by Sanjay Chanda:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.